Skip to main content

Multiple Sclerosis News (Page 3)

Related terms: MS

Patients Say Ketogenic Diet Aids Multiple Sclerosis Symptoms

MONDAY, Aug. 21, 2023 – Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition. Emma Wetmore,...

T-Cell Tolerant Fraction Can Predict Immunotherapy Toxicity

MONDAY, Aug. 21, 2023 – The T-cell tolerant fraction predicts clinically significant immune-related adverse events (irAEs) among patients with cancer treated with immune checkpoint inhibitors...

Fatigue Correlates With Disability in Patients With Relapsing-Remitting MS

MONDAY, Aug. 14, 2023 – A lower disability rate, better physical condition, and higher daily-living activity predict lower fatigue levels in patients with relapsing-remitting multiple sclerosis...

Fatigue Can Plague People With MS. Exercise May Help

WEDNESDAY, Aug. 9, 2023 – Patients with a type of multiple sclerosis (MS) known as relapsing-remitting MS could have less fatigue if they got more active and were in better physical shape, according...

2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis

THURSDAY, July 27, 2023 – Oral disease-modifying therapies (DMTs) predominated new initiations for treatment of multiple sclerosis (MS) in 2020, according to a study published online July 10 in JAMA...

The Earlier MS Is Treated, the Better

WEDNESDAY, July 26, 2023 – Patients who get treatment for multiple sclerosis at the earliest signs of disease may have a lower risk of disability later, new research suggests. Among nearly 600...

Early Treatment of Demyelination Events Cuts Long-Term Disability in MS

THURSDAY, July 20, 2023 – For multiple sclerosis patients with a first demyelinating event, earlier treatment initiation is associated with a reduction in the risk for long-term disability,...

Genes Identified in Association With Multiple Sclerosis Severity

FRIDAY, July 7, 2023 – Authors of a study published online June 28 in Nature have identified genetic markers associated with multiple sclerosis (MS) severity. Adil Harroud, M.D., from the University...

Discovery of MS 'Severity Gene' Could Lead to Better Treatments

THURSDAY, June 29, 2023 – For the first time, scientists have identified a genetic variant that may make some people with multiple sclerosis (MS) vulnerable to faster progression. In a study of more...

Pro-Inflammatory Diet Linked to Worsening Relapse Rate in MS

MONDAY, June 26, 2023 – For people with multiple sclerosis (MS), a pro-inflammatory diet is associated with worsening relapse rate and greater periventricular fluid-attenuated inversion recovery...

Pregnancy Seems to Ease MS Symptoms, and Research May Show Why

THURSDAY, June 15, 2023 – Women with multiple sclerosis temporarily get much better when pregnant, and researchers now think they know why. Pregnancy causes a downshift in a woman’s immune system, a...

Black Americans' Risk for MS May Be Higher Than Thought

WEDNESDAY, June 14, 2023 – For years, multiple sclerosis was seen as a disease that largely affects white people. But a new study finds that it's much more common among Black Americans than...

Rituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS

WEDNESDAY, June 14, 2023 – For patients with relapsing-remitting multiple sclerosis (MS), rituximab is not noninferior to ocrelizumab, according to a study published online June 12 in JAMA...

Tascenso ODT (fingolimod) Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient Support

Tascenso ODT is available to dispense to US multiple sclerosis (MS) patients Tascenso ODT is bioequivalent to, but not a generic of, Gilenya® (fingolimod) capsules1,2 On March 31st 2023 the Gilenya ...

Stress Across the Life Span Could Worsen MS

MONDAY, May 29, 2023 – Multiple sclerosis (MS) is a chronic disease that attacks the central nervous system and leaves patients suffering from a host of symptoms, and now new research finds life...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

prednisone, methylprednisolone, Medrol, valacyclovir, prednisolone, Tecfidera, dexamethasone, Gilenya, Ocrevus, dimethyl fumarate, Aubagio